Abstract

RECOVERY RATE AND HOSPITALIZATION STAY PATIENT TREATED WITH CORTICOSTEROIDS ALONE, ALONG WITH ANTIVIRAL ORAL AND INTRAVENOUS – FAVIPARAVIR & REMDESIVIR – 40 PATIENTS CLINICAL STUDY

Mayank Chugh* and Satender Tanwar

ABSTRACT

COVID 19 is a deadly Pandemic and effecting people throughout the world. Whole world is looking for the varied option for treatment and the second wave has almost caused the lot of mortality and morbidity.[1] Lot of patient came out with the complications such as Mucormycosis, raised glycemic level with many more adverse reaction. The corticosteroids being the most important remedy later proved to the disease enhancement and complication. In the similar way the antiviral drugs used are either Oral and intravenous not caused much of reduction n the mortality and hospitalization stay. No specific antiviral drugs have been approved for the treatment of COVID-19. Favipiravir is a promising drug for COVID-19 that decreases the hospital stay and the need for mechanical ventilation.[2] In this present study the 40 patient have been treated with three groups made treated with Corticosteroids alone, along with Antiviral Oral and Intravenous – Favipiravir & Remdesivir. After analyzing the data is found that none of the antiviral has made significant reduction in the hospitalization stay treated at IPD of chugh Multispeciality Hospital. Thus concluded that patient treated along with corticosteroids along with Antiviral oral and intravenous doesn’t make any significant changes in the hospital stay.

Keywords: COVID, Pandemic, Antiviral, Oral, Intravenous, Corticosteroids, Favipiravir and Remedisivir.